Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03752697 · ClinicalTrials.gov registry record

Metacognition in Neurological Injury

A clinical trial of Brain Injuries, sponsored by University of Nebraska Lincoln.

Active
Registry status
100
Enrollment target
1
Study location

NCT03752697 is a study of Brain Injuries that is active but no longer recruiting, run by University of Nebraska Lincoln. The registered enrollment target is 100 participants, below the 326-participant average among 22 other Brain Injuries trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03752697, a study of Brain Injuries, is active but no longer recruiting, sponsored by University of Nebraska Lincoln.

ACTIVE NOT RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the trajectory of metacognitive functioning throughout phases of recovery from neurological insult, and to determine its relationship to rehabilitation compliance and functional outcome. It is hypothesized that metacognitive accuracy improves over time, and is a significant predictor of engagement in rehabilitation activities.

Conditions Studied

Interventions

  • BEHAVIORAL metacognitive performance

Study Locations (1)

Nebraska

  • University of Nebraska-Lincoln - Lincoln

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-12-13
Est. Completion 2026-06

Sponsor

University of Nebraska Lincoln

24 total trials

What the Registry Record Tells You About NCT03752697

The ClinicalTrials.gov registry entry for NCT03752697 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 326-participant average among 22 other Brain Injuries trials with a reported enrollment target (69% lower). The listed sponsor is University of Nebraska Lincoln, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Brain Injuries appearing as the primary indexed condition, and to 1 intervention - of which metacognitive performance is the first listed.

NCT03752697 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT03752697 about?

NCT03752697 is a clinical study titled "Metacognition in Neurological Injury". The purpose of this study is to investigate the trajectory of metacognitive functioning throughout phases of recovery from neurological insult, and to determine its relationship to rehabilitation compliance and functional outcome. It is hypothesized that metacognitive accuracy improves over time, an...

What is the current status of trial NCT03752697?

This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2018-12-13. Estimated completion is 2026-06.

What conditions does trial NCT03752697 study?

This clinical trial studies the following conditions: Brain Injuries.

What interventions are being tested in trial NCT03752697?

The interventions under investigation include: metacognitive performance (BEHAVIORAL).

Who is sponsoring clinical trial NCT03752697?

This trial is sponsored by University of Nebraska Lincoln, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03752697 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.